Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Considering an Investment in a Healthcare Tech Startup? 5 Tips

Richard Quinn  |  December 20, 2016

2. Understand the Risks
Most startups fail; it’s just a fact. Whether you are contemplating a small investment or a multi-million-dollar deal, investors need to be realistic; success is not guaranteed. Most experts say that if you are stressing as you open your checkbook, the time might not be right for the transaction.

One helpful hint is to hire a financial advisor to walk you through the process (most rheumatology practices work with an accountant or brokers, so you might start by asking them questions). Financial advisors can provide guidance and assess the level of risk you are comfortable with.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

3. Be Ready to Write Another Check
If you find a great idea, a great bunch of people to work with and are willing to join the venture, don’t be surprised if the first investment is not your last. Small businesses and early-stage startups typically take a few years to turn a real profit. Most need to raise capital on a regular basis, via loans or additional investors.

“Be prepared to do follow-on investment to support the mission,” Mr. Cegielski says.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Market shifts will affect your investment, Mr. Cegielski says. Hot markets make it easy to raise capital, but those “windows can close” fast. “Hopefully, entrepreneurs have some good underlying partners to back them as they go forward,” he says, noting the best scenario is when investor and startup share the same goals.

4. Exit Strategy
Whether things go great or go sour, a clear exit strategy is smart business. At a minimum, your business partners should provide a list of competitors who might be interested in an acquisition. A strategy to go public is advisable, and other opportunities should be laid out up front. Discuss this with your financial advisor and potential partners before signing on the dotted line.

5. Be Patient
Investing is a lot like making a fine wine. You aren’t going to see returns on your investment the minute you mash the grapes.

“Ultimately, investors who are aligned with your mission will need patience. When you are attempting to do something substantial in scope, it takes time,” Mr. Cegielski says. “[Rheumatologists] need to be financially and mentally invested.”

Mr. Cegielski says the healthcare market is developing rapidly, with small solutions showing promise, more manageable technology costs and larger players (i.e., insurers, health systems) taking notice.

“As an entrepreneur, it is a really exciting time to be trying to address large problems that affects hundreds of millions and billions of people,” he says. “It’s not going to be long until everyone on the planet has access to some sort of connected, mobile device.”

Page: 1 2 3 | Single Page
Share: 

Filed under:Professional TopicsTechnology Tagged with:BusinessinvestmentLegalrheumatologistsriskTechnology

Related Articles

    Rheumatologists Saw a Gain in Compensation in 2020

    September 22, 2021

    Although patient volume temporarily declined due to the COVID-19 pandemic, rheumatologists saw a larger increase in compensation in 2020 than in 2019, according to a recent Medscape survey.

    What Rheumatologists Are Paid

    July 28, 2017

    A 2017 survey showed that rheumatologists’ pay has plateaued. And according to Anne Bass, MD, many cognitive fields, such as pediatrics and endocrinology, remain underpaid due to the current reimbursement structure…

    Medscape Survey Suggests 50% of Rheumatologists Experience Burnout

    May 13, 2021

    A new Medscape survey found that rheumatology has the second-highest burnout level among the 29 specialties included, with 50% of the rheuma­tology respondents saying they’re experiencing “burnout.” To which some rheumatologists are responding: Really? ad goes here:advert-1ADVERTISEMENTSCROLL TO CONTINUE“I was quite surprised by this,” says Beth Jonas, MD, chief of the Rheumatology, Allergy and Immunology…

    Happiness in Rheumatology

    March 12, 2019

    A 2019 report says rheumatologists are the happiest medical specialists outside of work. Simon Helfgott, MD, says this finding shows “we have been able to blend an interesting, intellectually stimulating profession and practice with the ability to help people.”..

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences